Law News: Explainer on the Risdiplam battle: GOI and Indian pharma must make the most of legitimate TRIPS flexibilities when multinational companies extend pate
What A Court Win Says About India’s Generics Case

132
Law News: Explainer on the Risdiplam battle: GOI and Indian pharma must make the most of legitimate TRIPS flexibilities when multinational companies extend pate